30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Biotechnology & Medical Research

Aevi Genomic Medicine Inc (GNMX)

Track

Stock chart
Ticker: GNMX Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
COLA MICHAEL F
Chief Executive Officer
1 purchase — total 250,000 USD
Buy 9 Jun 2020
Value US$707,572.86 | Price 410.53 | Shares 80,761
Buy 19 Dec 2019
Value US$2,285,221.20 | Price 398.51 | Shares 6,718
Sale 5 Dec 2019
Value US$549,232.77 | Price 0.13 | Shares 4,098,752
Buy 5 Dec 2019
Value US$274,616.38 | Price 0.13 | Shares 2,049,376
Buy 5 Dec 2019
Value US$274,616.38 | Price 0.13 | Shares 2,049,376
Buy 7 Nov 2018
Value US$24,150.00 | Price 1.15 | Shares 21,000
Buy 7 Nov 2018
Value US$24,570.00 | Price 1.17 | Shares 21,000
Buy 7 Nov 2018
Value US$30,212.00 | Price 1.16 | Shares 26,000
Buy 15 Aug 2018
Value US$2,448,979.20 | Price 0.96 | Shares 2,551,020
Buy 15 Aug 2018
Value US$2,448,979.20 | Price 0.96 | Shares 2,551,020
Buy 17 Oct 2017
Value US$24,999.66 | Price 1.26 | Shares 19,841
Buy 17 Oct 2017
Value US$50,000.58 | Price 1.26 | Shares 39,683
Buy 17 Oct 2017
Value US$530,500.32 | Price 1.26 | Shares 421,032
Buy 17 Oct 2017
Value US$149,999.22 | Price 1.26 | Shares 119,047
Buy 17 Oct 2017
Value US$75,000.24 | Price 1.26 | Shares 59,524
Buy 17 Oct 2017
Value US$94,500.00 | Price 1.26 | Shares 75,000
Buy 17 Oct 2017
Value US$24,999.66 | Price 1.26 | Shares 19,841
Buy 1 Sep 2017
Value US$100,530.00 | Price 1.20 | Shares 83,775
Buy 23 Aug 2017
Value US$6,840.00 | Price 1.20 | Shares 5,700
Buy 22 Aug 2017
Value US$5,593.20 | Price 1.20 | Shares 4,661
Buy 10 Aug 2017
Value US$24,359.30 | Price 1.19 | Shares 20,470
Buy 28 Apr 2017
Value US$156,670.00 | Price 1.57 | Shares 100,000
Buy 26 Apr 2017
Value US$154,340.00 | Price 1.54 | Shares 100,000
Buy 24 Mar 2017
Value US$86,121.60 | Price 1.60 | Shares 53,826
Buy 23 Mar 2017
Value US$7,528.00 | Price 1.60 | Shares 4,705
Buy 22 Mar 2017
Value US$1,790,000.00 | Price 1.79 | Shares 1,000,000
Buy 6 Oct 2015
Value US$999,999.00 | Price 6.50 | Shares 153,846
Buy 6 Oct 2015
Value US$249,990.00 | Price 6.50 | Shares 38,460
Buy 6 Oct 2015
Value US$99,996.00 | Price 6.50 | Shares 15,384
Buy 6 Oct 2015
Value US$99,996.00 | Price 6.50 | Shares 15,384
Sale 21 Sep 2015
Value US$944,457.00 | Price 9.96 | Shares 94,825
Buy 20 Mar 2015
Value US$422,500.00 | Price 8.45 | Shares 50,000
Sale 20 Mar 2015
Value US$422,500.00 | Price 8.45 | Shares 50,000
Buy 20 Feb 2015
Value US$377,500.00 | Price 7.55 | Shares 50,000
Buy 19 Feb 2015
Value US$738,000.00 | Price 7.38 | Shares 100,000
Buy 1 Dec 2014
Value US$99,999.00 | Price 4.10 | Shares 24,390
Buy 1 Dec 2014
Value US$1,500,001.40 | Price 4.10 | Shares 365,854
Buy 1 Dec 2014
Value US$9,999.90 | Price 4.10 | Shares 2,439
Buy 1 Dec 2014
Value US$25,001.80 | Price 4.10 | Shares 6,098
Buy 1 Dec 2014
Value US$250,001.60 | Price 4.10 | Shares 60,976
Buy 1 Dec 2014
Value US$99,999.00 | Price 4.10 | Shares 24,390
Buy 1 Dec 2014
Value US$49,999.50 | Price 4.10 | Shares 12,195
Buy 1 Dec 2014
Value US$199,998.00 | Price 4.10 | Shares 48,780
Buy 13 Jun 2014
Value US$222,936.00 | Price 7.96 | Shares 28,000
Buy 12 May 2014
Value US$414,300.00 | Price 6.91 | Shares 60,000
Planned sale 12 Feb 2014
Value US$100,512.00 | Price 9.00 | Shares 11,168
Planned sale 4 Feb 2014
Value US$160,000.00 | Price 8.00 | Shares 20,000
Planned sale 30 Jan 2014
Value US$183,750.00 | Price 7.50 | Shares 24,500
Planned sale 29 Jan 2014
Value US$3,750.00 | Price 7.50 | Shares 500
Planned sale 9 Jan 2014
Value US$230,577.54 | Price 6.69 | Shares 34,466
Planned sale 8 Jan 2014
Value US$297,792.36 | Price 6.54 | Shares 45,534
Buy 16 Dec 2013
Value US$26,004.60 | Price 5.78 | Shares 4,500
Buy 13 Dec 2013
Value US$107,422.00 | Price 5.37 | Shares 20,000
Sale 6 Dec 2013
Value US$13,000.00 | Price 6.50 | Shares 2,000
Sale 3 Dec 2013
Value US$31,750.00 | Price 6.35 | Shares 5,000
Sale 2 Dec 2013
Value US$94,161.00 | Price 6.28 | Shares 15,000
Buy 2 Dec 2013
Value US$131,780.00 | Price 6.59 | Shares 20,000
Buy 11 Nov 2013
Value US$170,122.50 | Price 6.80 | Shares 25,000
Buy 20 Sep 2013
Value US$129,996.00 | Price 6.50 | Shares 20,000
Buy 19 Sep 2013
Value US$111,478.00 | Price 5.57 | Shares 20,000
Buy 4 Jun 2013
Value US$2,947.68 | Price 4.14 | Shares 712
Buy 3 Jun 2013
Value US$1,192.32 | Price 4.14 | Shares 288
Sale 21 Sep 2012
Value US$4,360.00 | Price 10.90 | Shares 400
Sale 20 Sep 2012
Value US$55,495.44 | Price 10.92 | Shares 5,082
Sale 20 Sep 2012
Value US$3,846.50 | Price 10.99 | Shares 350
Sale 18 Sep 2012
Value US$51,200.00 | Price 10.24 | Shares 5,000
Sale 17 Sep 2012
Value US$61,740.00 | Price 10.29 | Shares 6,000
Sale 14 Sep 2012
Value US$32,295.18 | Price 10.74 | Shares 3,007
Sale 14 Sep 2012
Value US$42,920.00 | Price 10.73 | Shares 4,000
Sale 13 Sep 2012
Value US$209,181.18 | Price 10.66 | Shares 19,623
Sale 30 Aug 2012
Value US$9,121.00 | Price 13.03 | Shares 700
Sale 24 Aug 2012
Value US$136,687.50 | Price 12.50 | Shares 10,935
Buy 13 Apr 2011
Value US$5,000,000.00 | Price 5.00 | Shares 1,000,000
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2020-06-11 2020-06-09 B Purchase
1.7
COLA MICHAEL F

Chief Executive Officer

Executive Director
80,761 +15.4%
410.53
US$707,573 		80,761 +15.4% 410.53 US$707,573
2020-02-07 2019-12-19 B Purchase
ASTRAZENECA PLC
Large shareholder
6,718
398.51
US$2,285,221 		6,718 398.51 US$2,285,221
2019-12-09 2019-12-05 S Sale BARER SOL J Non-Executive Director
74,287 +41.3%
393.95
US$1,422,142 		74,287 +41.3% 393.95 US$1,422,142
2019-12-09 2019-12-05 B Purchase COLA MICHAEL F

President and CEO

Executive Director
2,049,376 +938.0%
0.13
US$274,616 		2,049,376 +938.0% 0.13 US$274,616
2019-12-09 2019-12-05 B Purchase NEIL GARRY ARTHUR

Chief Scientific Officer

Officer
2,049,376 +1785.6%
0.13
US$274,616 		2,049,376 +1785.6% 0.13 US$274,616
2018-11-13 2018-11-07 B Purchase GRANO JOSEPH J JR Non-Executive Director
21,000 +58.7%
1.15
US$24,150 		21,000 +58.7% 1.15 US$24,150
2018-11-13 2018-11-07 B Purchase GRANO JOSEPH J JR Non-Executive Director
21,000 +350.0%
1.17
US$24,570 		21,000 +350.0% 1.17 US$24,570
2018-11-13 2018-11-07 B Purchase GRANO JOSEPH J JR Non-Executive Director
26,000 +52.3%
1.16
US$30,212 		26,000 +52.3% 1.16 US$30,212
2018-08-17 2018-08-15 B Purchase Children's Hospital of Philadelphia Foundation Large shareholder
2,551,020 +16.1%
0.96
US$2,448,979 		2,551,020 +16.1% 0.96 US$2,448,979
2018-08-17 2018-08-15 B Purchase BARER SOL J Non-Executive Director
2,551,020 +inf%
0.96
US$2,448,979 		2,551,020 +inf% 0.96 US$2,448,979
2017-10-18 2017-10-17 B Purchase BAUER EUGENE A
19,841 +13.6%
1.26
US$25,000 		19,841 +13.6% 1.26 US$25,000
2017-10-18 2017-10-17 B Purchase GANTZ WILBUR H
39,683 +126.4%
1.26
US$50,001 		39,683 +126.4% 1.26 US$50,001
2017-10-18 2017-10-17 B Purchase BARER SOL J
421,032 +69.4%
1.26
US$530,500 		421,032 +69.4% 1.26 US$530,500
2017-10-18 2017-10-17 B Purchase COLA MICHAEL F

President and CEO

Executive Director
119,047 +119.7%
1.26
US$149,999 		119,047 +119.7% 1.26 US$149,999
2017-10-18 2017-10-17 B Purchase Duncan Barbara Gayle
59,524 +inf%
1.26
US$75,000 		59,524 +inf% 1.26 US$75,000
2017-10-18 2017-10-17 B Purchase NEIL GARRY ARTHUR

Chief Scientific Officer
75,000 +188.6%
1.26
US$94,500 		75,000 +188.6% 1.26 US$94,500
2017-10-18 2017-10-17 B Purchase CLEMOW ALASTAIR J
19,841 +52.6%
1.26
US$25,000 		19,841 +52.6% 1.26 US$25,000
2017-09-06 2017-09-01 B Purchase HARPER PHILIP R Large shareholder
83,775 +1.7%
1.20
US$100,530 		83,775 +1.7% 1.20 US$100,530
2017-08-24 2017-08-23 B Purchase HARPER PHILIP R Large shareholder
5,700 +0.1%
1.20
US$6,840 		5,700 +0.1% 1.20 US$6,840
2017-08-24 2017-08-22 B Purchase HARPER PHILIP R Large shareholder
4,661 +0.1%
1.20
US$5,593 		4,661 +0.1% 1.20 US$5,593
2017-08-14 2017-08-10 B Purchase HARPER PHILIP R Large shareholder
20,470 +0.4%
1.19
US$24,359 		20,470 +0.4% 1.19 US$24,359
2017-05-01 2017-04-28 B Purchase BARER SOL J Non-Executive Director
100,000 +19.7%
1.57
US$156,670 		100,000 +19.7% 1.57 US$156,670
2017-04-27 2017-04-26 B Purchase BARER SOL J
100,000 +24.6%
1.54
US$154,340 		100,000 +24.6% 1.54 US$154,340
2017-03-27 2017-03-24 B Purchase HARPER PHILIP R Large shareholder
53,826 +1.1%
1.60
US$86,122 		53,826 +1.1% 1.60 US$86,122
2017-03-27 2017-03-23 B Purchase HARPER PHILIP R Large shareholder
4,705 +0.1%
1.60
US$7,528 		4,705 +0.1% 1.60 US$7,528
2017-03-27 2017-03-22 B Purchase HARPER PHILIP R Large shareholder
1,000,000 +26.4%
1.79
US$1,790,000 		1,000,000 +26.4% 1.79 US$1,790,000
2015-10-08 2015-10-06 B Purchase BARER SOL J Non-Executive Director
153,846 +inf%
6.50
US$999,999 		153,846 +inf% 6.50 US$999,999
2015-10-08 2015-10-06 B Purchase COLA MICHAEL F

President and CEO

Executive Director
38,460 +63.1%
6.50
US$249,990 		38,460 +63.1% 6.50 US$249,990
2015-10-08 2015-10-06 B Purchase NEIL GARRY ARTHUR

Chief Scientific Officer

Officer
15,384 +63.1%
6.50
US$99,996 		15,384 +63.1% 6.50 US$99,996
2015-10-08 2015-10-06 B Purchase GRANO JOSEPH J JR Non-Executive Director
15,384 +inf%
6.50
US$99,996 		15,384 +inf% 6.50 US$99,996
2015-09-23 2015-09-21 S Sale BLECH ISAAC Non-Executive Director Large shareholder
94,825 -5.1%
9.96
US$944,457 		94,825 -5.1% 9.96 US$944,457
2015-03-23 2015-03-20 B Purchase BARER SOL J Non-Executive Director
50,000 +14.0%
8.45
US$422,500 		50,000 +14.0% 8.45 US$422,500
2015-03-23 2015-03-20 S Sale BAUER EUGENE A Non-Executive Director
50,000 -25.5%
8.45
US$422,500 		50,000 -25.5% 8.45 US$422,500
2015-02-23 2015-02-20 B Purchase BARER SOL J Non-Executive Director
50,000 +16.3%
7.55
US$377,500 		50,000 +16.3% 7.55 US$377,500
2015-02-23 2015-02-19 B Purchase BARER SOL J Non-Executive Director
100,000 +48.3%
7.38
US$738,000 		100,000 +48.3% 7.38 US$738,000
2014-12-02 2014-12-01 B Purchase GANTZ WILBUR H Non-Executive Director
24,390 +348.4%
4.10
US$99,999 		24,390 +348.4% 4.10 US$99,999
2014-12-02 2014-12-01 B Purchase BARER SOL J Non-Executive Director
365,854 +inf%
4.10
US$1,500,001 		365,854 +inf% 4.10 US$1,500,001
2014-12-02 2014-12-01 B Purchase MCMURRAY STEPHEN D Non-Executive Director
2,439 +2.6%
4.10
US$10,000 		2,439 +2.6% 4.10 US$10,000
2014-12-02 2014-12-01 B Purchase Applebaum Scott

Chief Legal Officer

Officer
6,098 +inf%
4.10
US$25,002 		6,098 +inf% 4.10 US$25,002
2014-12-02 2014-12-01 B Purchase COLA MICHAEL F

President and CEO

Executive Director
60,976 +inf%
4.10
US$250,002 		60,976 +inf% 4.10 US$250,002
2014-12-02 2014-12-01 B Purchase NEIL GARRY ARTHUR

Global Head of R&D

Officer
24,390 +inf%
4.10
US$99,999 		24,390 +inf% 4.10 US$99,999
2014-12-02 2014-12-01 B Purchase CLEMOW ALASTAIR J T Non-Executive Director
12,195 +47.8%
4.10
US$50,000 		12,195 +47.8% 4.10 US$50,000
2014-12-02 2014-12-01 B Purchase GRANO JOSEPH J JR Non-Executive Director
48,780 +696.9%
4.10
US$199,998 		48,780 +696.9% 4.10 US$199,998
2014-06-16 2014-06-13 B Purchase BARER SOL J Non-Executive Director
28,000 +15.6%
7.96
US$222,936 		28,000 +15.6% 7.96 US$222,936
2014-05-13 2014-05-12 B Purchase BARER SOL J Non-Executive Director
60,000 +50.4%
6.91
US$414,300 		60,000 +50.4% 6.91 US$414,300
2014-02-14 2014-02-12 PlS Planned sale Pearlman Andrew Non-Executive Director
11,168 -21.6%
9.00
US$100,512 		11,168 -21.6% 9.00 US$100,512
2014-02-06 2014-02-04 PlS Planned sale Pearlman Andrew Non-Executive Director
20,000 -33.0%
8.00
US$160,000 		20,000 -33.0% 8.00 US$160,000
2014-01-31 2014-01-30 PlS Planned sale Pearlman Andrew Non-Executive Director
24,500 -37.7%
7.50
US$183,750 		24,500 -37.7% 7.50 US$183,750
2014-01-31 2014-01-29 PlS Planned sale Pearlman Andrew Non-Executive Director
500 -1.2%
7.50
US$3,750 		500 -1.2% 7.50 US$3,750
2014-01-10 2014-01-09 PlS Planned sale Pearlman Andrew Non-Executive Director
34,466 -45.9%
6.69
US$230,578 		34,466 -45.9% 6.69 US$230,578
2014-01-10 2014-01-08 PlS Planned sale Pearlman Andrew Non-Executive Director
45,534 -52.9%
6.54
US$297,792 		45,534 -52.9% 6.54 US$297,792
2013-12-18 2013-12-16 B Purchase CLEMOW ALASTAIR J T Non-Executive Director
4,500 +32.1%
5.78
US$26,005 		4,500 +32.1% 5.78 US$26,005
2013-12-16 2013-12-13 B Purchase BARER SOL J Non-Executive Director
20,000 +21.7%
5.37
US$107,422 		20,000 +21.7% 5.37 US$107,422
2013-12-09 2013-12-06 S Sale DELLIO CLARENCE L

Chief Operating Officer

Officer
2,000 -44.4%
6.50
US$13,000 		2,000 -44.4% 6.50 US$13,000
2013-12-04 2013-12-03 S Sale BAUER EUGENE A Non-Executive Director
5,000 -2.5%
6.35
US$31,750 		5,000 -2.5% 6.35 US$31,750
2013-12-04 2013-12-02 S Sale BAUER EUGENE A Non-Executive Director
15,000 -6.9%
6.28
US$94,161 		15,000 -6.9% 6.28 US$94,161
2013-12-03 2013-12-02 B Purchase BARER SOL J Non-Executive Director
20,000 +27.8%
6.59
US$131,780 		20,000 +27.8% 6.59 US$131,780
2013-11-12 2013-11-11 B Purchase BARER SOL J Non-Executive Director
25,000 +53.2%
6.80
US$170,122 		25,000 +53.2% 6.80 US$170,122
2013-09-20 2013-09-20 B Purchase BARER SOL J
20,000 +74.1%
6.50
US$129,996 		20,000 +74.1% 6.50 US$129,996
2013-09-19 2013-09-19 B Purchase BARER SOL J
20,000 +285.7%
5.57
US$111,478 		20,000 +285.7% 5.57 US$111,478
2013-06-05 2013-06-04 B Purchase DELLIO CLARENCE L

Chief Operating Officer

Officer
712 +18.8%
4.14
US$2,948 		712 +18.8% 4.14 US$2,948
2013-06-05 2013-06-03 B Purchase DELLIO CLARENCE L

Chief Operating Officer

Officer
288 +8.2%
4.14
US$1,192 		288 +8.2% 4.14 US$1,192
2012-09-27 2012-09-21 S Sale Bellin Phyllis K.

See Remarks

Officer
400 -3.6%
10.90
US$4,360 		400 -3.6% 10.90 US$4,360
2012-09-27 2012-09-20 S Sale Bellin Phyllis K.

See Remarks

Officer
5,082 -31.5%
10.92
US$55,495 		5,082 -31.5% 10.92 US$55,495
2012-09-27 2012-09-20 S Sale Bellomo Stephen

See Remarks

Officer
350 -100.0%
10.99
US$3,846 		350 -100.0% 10.99 US$3,846
2012-09-19 2012-09-18 S Sale Pearlman Andrew

President and CEO

Executive Director
5,000 -13.0%
10.24
US$51,200 		5,000 -13.0% 10.24 US$51,200
2012-09-19 2012-09-17 S Sale Pearlman Andrew

President and CEO

Executive Director
6,000 -13.5%
10.29
US$61,740 		6,000 -13.5% 10.29 US$61,740
2012-09-18 2012-09-14 S Sale DELLIO CLARENCE L

Chief Operating Officer

Officer
3,007 -100.0%
10.74
US$32,295 		3,007 -100.0% 10.74 US$32,295
2012-09-17 2012-09-14 S Sale Pearlman Andrew

President and CEO

Executive Director
4,000 -8.2%
10.73
US$42,920 		4,000 -8.2% 10.73 US$42,920
2012-09-17 2012-09-13 S Sale Pearlman Andrew

President and CEO

Executive Director
19,623 -28.8%
10.66
US$209,181 		19,623 -28.8% 10.66 US$209,181
2012-09-04 2012-08-30 S Sale KANTER JOEL S Non-Executive Director
700 -0.7%
13.03
US$9,121 		700 -0.7% 13.03 US$9,121
2012-08-28 2012-08-24 S Sale MCMURRAY STEPHEN D Non-Executive Director
10,935 -12.0%
12.50
US$136,688 		10,935 -12.0% 12.50 US$136,688
2011-04-15 2011-04-13 B Purchase BLECH ISAAC

See Footnote 3

Large shareholder
1,000,000 +inf%
5.00
US$5,000,000 		1,000,000 +inf% 5.00 US$5,000,000
Explore more

More insider trading research around Aevi Genomic Medicine Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America